Yearly, over 35,500 people nationwide are diagnosed with primary brain or central nervous system tumors, while an estimated 17,380 people are diagnosed with brain metastases. As co-founders of the world-renowned Brain Tumor Center at NewYork–Presbyterian/Columbia University Medical Center, we see approximately 400 new brain and spinal tumor patients annually, from the United States and abroad. Together with a multidiscplinary team of related specialists, we strive to provide state-of-the-art diagnosis and treatment options, tailored to each patient's specific history, needs, and concerns.
Our expert Brain Tumor Center team includes specially-trained:
- Radiation Oncologists
- Palliative Care Specialists
- Nurse Practitioners
- Social Workers
- and other Health Practitioners
Our clinical activities are combined with extensive research efforts that range from basic laboratory research, including the Bartolli Brain Tumor Laboratory, to better understand how the most common brain tumors develop and grow, to applied research focused on developing and testing new treatments for the most common types of brain tumors, to clinical trials of novel therapies in patients. Our broad network of investigators at Columbia University Medical Center have worked together to pioneer experimental models of brain tumors and the development of several novel treatments, supported by grants from the National Institutes of Health. In both our patient care and research endeavors, our effort and commitment toward improving the outcome of patients with brain tumors never waivers.